tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Clinical Progress and Efficacy of CytomX Therapeutics’ CX-2051 Justifies Buy Rating
PremiumRatingsPromising Clinical Progress and Efficacy of CytomX Therapeutics’ CX-2051 Justifies Buy Rating
25d ago
CytomX Therapeutics Reports Strong Financial Turnaround
Premium
Company Announcements
CytomX Therapeutics Reports Strong Financial Turnaround
29d ago
CytomX Therapeutics reports Q2 EPS 0c, consensus (6c)
Premium
The Fly
CytomX Therapeutics reports Q2 EPS 0c, consensus (6c)
29d ago
Promising Developments in CytomX Therapeutics’ Clinical Trials Boost Buy Rating for CX-801
PremiumRatingsPromising Developments in CytomX Therapeutics’ Clinical Trials Boost Buy Rating for CX-801
4M ago
CytomX Therapeutics announces first patient dosed in Phase 1 study of CX-801
Premium
The Fly
CytomX Therapeutics announces first patient dosed in Phase 1 study of CX-801
4M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100